CYTO: Altamira Therapeutics Ltd Company Short-Term Debt

Symbol and logo of brand altamiratherapeutics.com (CYTO)

Altamira Therapeutics (CYTO) is developing inhalation agents to combat pulmonary pathologies and allergies using flexible substance transport methods. The market valuation trend for the asset based on the separate_debt_short metric is 0.00. The business's profitability is based on patent protection for nasal sprays used in RNA therapy. Currently, Altamira Therapeutics is focusing on licensing its developments to industry behemoths, moving away from mergers and heavy assets.

CYTO (altamiratherapeutics.com) Company Short-Term Debts history from 07/04/2022 to 01/04/2025

Analytical breakdowns and data insights for company Altamira Therapeutics Ltd (CYTO)

- current quotes and average value forecast:
Price Chart Auris Medical|CYTO - Fair Value Consensus
- market capitalization information:
Market Value Altamira Therapeutics Ltd.|CYTO - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Altamira Therapeutics|CYTO - Book Capitalization|Market Cap to Net Assets Ratio altamiratherapeutics.com|CYTO - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Altamira Therapeutics|CYTO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Auris Medical|CYTO - Company Cumulative Indebtedness|Debts to Book Capitalization Altamira Therapeutics Ltd.|CYTO - Company Long-Term Loans and Borrowings|Company Short-Term Debts Altamira Therapeutics|Quick Liquidity altamiratherapeutics.com
- net income and valuation multiples indicators:
CYTO - Final Profit
Summary company analytics:altamiratherapeutics.com (CYTO)
Mass-produced product of Altamira Therapeutics

Altamira Therapeutics' development in the RNA delivery segment requires precise liquidity management to sustain clinical trials. An analysis of financial debts with a maturity of up to one year, aggregating all short-term liabilities, allows for an assessment of the company's solvency and refinancing risk; minimal values for this indicator confirm balance sheet stability but may suggest a conservative approach to scaling the business.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TECX (Tectonic Therapeutic)|Company Short-Term Debts Tonix Pharma TNXP|SXTC - Company Short-Term Debt|EPRX: Company Short-Term Debt|BHST (BioHarvest Sciences) - Company Current Liabilities|EXOZ: Amount of Current Liabilities|ORMP (Oramed) - Company Short-Term Debts|Company Short-Term Debts Entera Bio Corp|Company Short-Term Debt MindWalk (HYFT)|Company Current Liabilities ABVC BioPharma, Inc ABVC|Company Short-Term Debts CPIX (Cumberland Pharmaceuticals)|Short-Term Debt Volume quantumbiopharma.com (QNTM)|FGEN - Company Short-Term Debt|Company Short-Term Loans and Borrowings TELO (Telomir Pharmaceuticals Inc)|RANI: Company Short-Term Debts|Synergy CHC (SNYR) - Company Short-Term Debts|Company Current Liabilities RLYB|LEXX: Company Short-Term Loans and Borrowings|Company Current Liabilities PULM (Pulmatrix)|Amount of Current Liabilities PTHL|Company Short-Term Debts APM (Aptorum Group)|Company Short-Term Loans and Borrowings LYRA|Impact BioMedical - Company Short-Term Debts|Short-Term Debt TNF Pharmaceuticals|cbdmd.com (YCBD) - Company Short-Term Debt|PainReform Ltd - Company Short-Term Loans and Borrowings|LIPO (Lipella) - Company Short-Term Debts|Company Short-Term Debts OptiNose Corp|Company Short-Term Debt Pieris Pharmaceuticals (PIRS)|PROC: Current Liabilities|Company Short-Term Debts PTPI (Petros Pharmaceuticals, Inc.)|Qilian International Holding Group (QLI) - Short-Term Debt|SLRN: Company Current Liabilities|TFFP - Company Short-Term Debts